• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TRP
Click for more information
3.64% 26.5¢

TISSUE REPAIR LTD

Market Cap $16.02M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company... Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company developing second generation wound healing agents. The Company's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The Company is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a β-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TRP
Ann: Chairman's Address 		08/11/24 42 6.2K
08/11/24 Last post  BalkanBroker Comments Created with Sketch.  42  Views Created with Sketch.  6.2K 
TRP
Ann: AGM Presentation 		05/11/24 1 419
05/11/24 Last post  jonromer Comments Created with Sketch.  1  Views Created with Sketch.  419 
TRP
Ann: Initial Director's Interest Notice - AM 		29/10/24 0 136
29/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  136 
TRP
Ann: Initial Director's Interest Notice - PK 		29/10/24 0 153
29/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  153 
TRP
Ann: Final Director's Interest Notice - MS 		28/10/24 0 132
28/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  132 
TRP
Ann: Final Director's Interest Notice - BG 		28/10/24 0 129
28/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  129 
TRP
Ann: Final Director's Interest Notice - JL 		28/10/24 0 147
28/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  147 
TRP
Ann: Results of Meeting 		25/10/24 1 313
25/10/24 Last post  uranium69 Comments Created with Sketch.  1  Views Created with Sketch.  313 

See All Discussions arrow Created with Sketch.

Timeline

Initial Director's Interest Notice - AM
29 Oct 17:05
 
Initial Director's Interest Notice - PK
29 Oct 10:59
 
Final Director's Interest Notice - MS
28 Oct 12:51
 
Final Director's Interest Notice - BG
28 Oct 12:50
 
Final Director's Interest Notice - JL
28 Oct 12:40
 
Results of Meeting
25 Oct 12:30
 
View More arrow Created with Sketch.

Featured News

NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
NEWS HotCopper Highlights: Your most watched and most discussed stocks this week
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
(20min delay)
Last
26.5¢ 		Change
-0.010(3.64%) 		Mkt cap ! $16.02M
Open High Low Value Volume
26.0¢ 27.5¢ 26.0¢ $34.99K 132.7K

Buyers (Bids)

No. Vol. Price($)
2 16105 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 42309 1
View Market Depth
Last trade - 15.15pm 08/11/2024 (20 minute delay) ?
Last
26.5¢ 		  Change
-0.010 ( 1.92 %)
Open High Low Volume
27.0¢ 27.0¢ 26.5¢ 34055
Last updated 15.15pm 08/11/2024 ?
TRP (ASX) Chart

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Universal Biosensors flat despite fresh deal with US medical product distributor Universal Biosensors shares were flat on Friday, even as the microcap healthcare company inked a US distribution deal.
HotCopper Highlights: Your most watched and most discussed stocks this week In this new segment, we dive into the backend of HotCopper to reveal what you've been watching and discussing this week.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive The Dow Jones finished up +3% on election day; the NASDAQ and S&P weren’t far behind. Gold traders aren’t sure what to do.
Imugene kicks off Australian trial for blood cancer treatment Imugene Ltd has opened its first Australian trial for a Phase 1b clinical trial to test CAR T cell therapy azer-cel

Featured News

EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.